Harry Lamble
Keine laufenden Positionen mehr
Aktive Positionen von Harry Lamble
| Unternehmen | Position | Beginn | Ende |
|---|
Karriereverlauf von Harry Lamble
Ehemalige bekannte Positionen von Harry Lamble
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Sense Biodetection Ltd.
 Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2014 | 30.01.2023 |
| Vorstandsvorsitzender | 01.01.2014 | 20.07.2021 | |
| Gründer | 01.01.2014 | 30.01.2023 | |
| Corporate Officer/Principal | 20.07.2021 | 30.01.2023 | |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Direktor/Vorstandsmitglied | 17.12.2009 | - |
| Unternehmenssekretär | - | - |
Ausbildung von Harry Lamble
| University of Bath | Doctorate Degree |
| Cranfield University | Masters Business Admin |
Statistik
International
| Vereinigtes Königreich | 5 |
Operativ
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Sense Biodetection Ltd.
Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom. | Health Services |
- Börse
- Insiders
- Harry Lamble
- Erfahrung
